Get Connected:


Latest News

PBM Outcomes-Based Payment Model Launch Highlights AJPB Week in Review
Top articles of the week from The American Journal of Pharmacy Benefits.
The 2016 Naloxone App Competition will create an application to link carriers of naloxone with those experiencing an opioid overdose.
Affordable Care Act premiums were as much as 35% lower than employer premiums.
Fetuses born to mothers with diabetes are more likely to have hypoglycemia, abnormal size, and malformation.
Cubicin treats complicated skin and skin structure infections caused by susceptible isolates of the following Gram-positive bacteria.
Metformin found to impact metabolic pathways in type 2 diabetes.
Top news of the day from across the healthcare landscape.
Abaloparatide can prevent bone fractures in postmenopausal women with osteoporosis.
View More >

From the Journals

This study examines variations in overall use, and potentially inappropriate use, of non-warfarin direct-acting oral anticoagulants across sites within the Veterans Health Administration.
Individuals with treatment-resistant depression do not achieve and sustain remission after multiple pharmacotherapies, with an unknown impact on employment. This study investigates the expenditures of TRD from a private-payer perspective in Canada.
This study highlights the implications of noncompliance with the use of in-network providers for immunization services, shedding light on value-based benefits design to promote access to recommended vaccinations.
Specialty-focused partial-fill plan designs are gaining traction, with conflicting opinions on whether they reduce waste or impact the quality of care.
This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.
This study evaluates whether provider adoption and use of formulary decision support for e-prescribing are directly associated with significant prescriber and patient behavior change.
The development and implementation of a rare disease management program by healthcare providers and payors could greatly assist in improving the clinical, psycho-social and economic impacts for this patient population.   
Upcoming Partner Events